Clinical Trial Update: Evaluate the Efficacy and Safety of MUSK Pill on Coronary Microvascular Dysfunction [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating MUSK Pill for coronary microvascular dysfunction with angina-related conditions; efficacy and safety data are currently not available.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Angina Pectoris
• Coronary Heart Disease
• Non-obstructive Coronary Artery Disease

Drugs mentioned

• MUSK Pill

Snippet

Sponsor: Shanghai Hutchison Pharmaceuticals Limited | Conditions: Angina Pectoris, Coronary Heart Disease | Phase 4 | Status: UNKNOWN